Narrative Review of Chloroquine and Hydroxychloroquine for Treatment of Coronavirus Disease 2019

Muhammad Jahngir; Muhammad S Ghaffar; Jawad F Kirmani; Pegah Ghafourian

Narrative Review of Chloroquine and Hydroxychloroquine for Treatment of Coronavirus Disease 2019

Muhammad Jahngir
, Muhammad S Ghaffar
, Jawad F Kirmani
, Pegah Ghafourian

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Default journal
State	Published - Jan 1 2021

Disciplines

Virology
Medicine and Health Sciences

Cite this

@article{fb07ed4ecb6344b7b2a225f5de81d50b,

title = "Narrative Review of Chloroquine and Hydroxychloroquine for Treatment of Coronavirus Disease 2019",

author = "Muhammad Jahngir and Ghaffar, \{Muhammad S\} and Kirmani, \{Jawad F\} and Pegah Ghafourian",

note = "Background- There continues to be considerable interest in use of chloroquine and its derivatives for both prevention and treatment of coronavirus disease 2019 (COVID-19) caused by severe respiratory distress syndrome coronavirus 2 (SARS-CoV-2).",

year = "2021",

month = jan,

day = "1",

language = "American English",

journal = "Default journal",

}

TY - JOUR

T1 - Narrative Review of Chloroquine and Hydroxychloroquine for Treatment of Coronavirus Disease 2019

AU - Jahngir, Muhammad

AU - Ghaffar, Muhammad S

AU - Kirmani, Jawad F

AU - Ghafourian, Pegah

N1 - Background- There continues to be considerable interest in use of chloroquine and its derivatives for both prevention and treatment of coronavirus disease 2019 (COVID-19) caused by severe respiratory distress syndrome coronavirus 2 (SARS-CoV-2).

PY - 2021/1/1

Y1 - 2021/1/1

UR - https://scholarlycommons.hcahealthcare.com/infectious/37/

M3 - Article

JO - Default journal

JF - Default journal

ER -

Narrative Review of Chloroquine and Hydroxychloroquine for Treatment of Coronavirus Disease 2019

Disciplines

Other files and links

Cite this